CDXS Codexis Inc

Codexis Inc is a biotech company. It develops proprietary biocatalysts-enzymes or microbes that initiate or accelerate chemical reactions. It offers its products to the pharmaceutical industry. The company also develops advanced biofuels.

$10.88  +0.42 (4.02%)
As of 07/01/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/22/2010
Outstanding shares:  65,304,060
Average volume:  808,836
Market cap:   $683,080,468
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B5LL2C2
Valuation   (See tab for details)
PE ratio:   -34.55
PB ratio:   4.48
PS ratio:   5.60
Return on equity:   -12.96%
Net income %:   -16.85%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy